Bladder cancer - What's new?

被引：0

作者：

Gschwend, J. ^{[1
]}

机构：

[1] Univ Klin Urol, Klin Urol & Kinderurol, D-89075 Ulm, Germany

来源：

UROLOGE | 2006年 / 45卷 / 04期

关键词：

D O I：

10.1007/s00120-006-1040-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：496 / 498

页数：3

共 15 条

[1] Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data [J].

Abol-Enein, H ;

Bassi, P ;

Boyer, M ;

Coppin, CML ;

Cortesi, E ;

Grossman, HB ;

Hall, RR ;

Horwich, A ;

Malmström, PU ;

Martinez-Piñeiro, JA ;

Sengelov, L ;

Sherif, A ;

Wallace, DMA ;

Bono, AV ;

Goebell, PJ ;

Groshen, S ;

Torti, FM ;

Clarke, NW ;

Roberts, JT ;

Sylvester, R ;

Parmar, MKB ;

Stewart, LA ;

Tierney, JF ;

Vale, CL .

EUROPEAN UROLOGY, 2005, 48 (02) :202-206

[2] Bladder cancer outcome and subtype classification by gene expression [J].

Blaveri, E ;

Simko, JP ;

Korkola, JE ;

Brewer, JL ;

Baehner, F ;

Mehta, K ;

DeVries, S ;

Koppie, T ;

Pejavar, S ;

Carroll, P ;

Waldman, FM .

CLINICAL CANCER RESEARCH, 2005, 11 (11) :4044-4055

[3] Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].

Bono, AV ;

Goebell, PJ ;

Groshen, S ;

Lehmann, J ;

Studer, U ;

Torti, FM ;

Abol-Enein, H ;

Bassi, P ;

Boyer, M ;

Coppin, CML ;

Cortesi, E ;

Hall, RR ;

Horwich, A ;

Malmström, PU ;

Martínez-Piñeiro, JA ;

Sengelov, L ;

Sherif, A ;

Wallace, DMA ;

Clarke, NW ;

Roberts, JT ;

Sylvester, R ;

Parmar, MKB ;

Stewart, LA ;

Tierney, JF ;

Vale, CL .

EUROPEAN UROLOGY, 2005, 48 (02) :189-201

[4] Bacillus Calmette-Guerin versus epirubicin for primary. secondary or concurrent carcinoma in situ of the bladder: Results of a european organization for the research and treatment of Cancer-Genito-urinary Group phase III trial (30906) [J].

De Reijke, TM ;

Kurth, KH ;

Sylvester, RJ ;

Hall, RR ;

Brausi, M ;

van de Beek, K ;

Landsoght, KEJ ;

Carpentier, PC .

JOURNAL OF UROLOGY, 2005, 173 (02) :405-409

[5] Urinary bladder cancer: Preoperative nodal staging with ferumoxtran-10-enhanced MR imaging [J].

Deserno, WMLLG ;

Harisinghani, MG ;

Taupitz, M ;

Jager, GJ ;

Witjes, JA ;

Mulders, PF ;

van de Kaa, CAH ;

Kaufmann, D ;

Barentsz, JO .

RADIOLOGY, 2004, 233 (02) :449-456

[6] A molecular signature in superficial bladder carcinoma predicts clinical outcome [J].

Dyrskjot, L ;

Zieger, K ;

Kruhoffer, M ;

Thykjaer, T ;

Jensen, JL ;

Primdahl, H ;

Aziz, N ;

Marcussen, N ;

Moller, K ;

Orntoft, AF .

CLINICAL CANCER RESEARCH, 2005, 11 (11) :4029-4036

[7] Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor [J].

Fleischmann, A ;

Thalmann, GN ;

Markwalder, R ;

Studer, UE .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2358-2365

[8]

GSCHWEND JE, 2004, J UROLOGY, V171, pA304

[9] Noninvasive detection of clinically occult lymph-node metastases in prostate cancer [J].

Harisinghani, MG ;

Barentsz, J ;

Hahn, PF ;

Deserno, WM ;

Tabatabaei, S ;

van de Kaa, CH ;

de la Rosette, J ;

Weissleder, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) :2491-U5

[10] Improved detection and treatment of bladder cancer using hexaminolevulinate imaging:: A prospective, phase III multicenter study [J].

Jocham, D ;

Witjes, F ;

Wagner, S ;

Zeylemaker, B ;

van Moorselaar, J ;

Grimm, MO ;

Muschter, R ;

Popken, G ;

König, F ;

Knüchel, R ;

Kurth, KH .

JOURNAL OF UROLOGY, 2005, 174 (03) :862-866

← 1 2 →